In sporadic CRC, loss of APC function is a key event to initiate an adenoma, followed by the activation of KRAS, COX-2, and other factors; whereas the abnormality of TP53 usually occurs in the late stage of disease progression and drug resistance (25, 26). The gene discussed is KRAS; the disease is colorectal carcinoma.